← FDA Drug Approvals (Drugs@FDA)
ELIGLUSTAT TARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2024-12-10
Drug application
- FDA Application #
ANDA212369- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ELIGLUSTAT TARTRATE
- Generic name
- Eliglustat Tartrate
- Active ingredients
- ELIGLUSTAT TARTRATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CIPLA
- First approval
- 2024-12-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown